Yoshihiro Matsumura

Associate Professor

Tohoku Daigaku Daigakuin Igakukei Kenkyuka Igakubu

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yoshihiro Matsumura is an Associate Professor at Tohoku Daigaku Daigakuin Igakukei Kenkyuka Igakubu in Japan. His research areas include epitranscriptomics in metabolic disease, the impact of hypoxia on tumor growth, and the epigenetic regulation of adipocyte function. He has published extensively on topics such as the role of PPARα in non-alcoholic steatohepatitis and the mechanisms of adipogenesis.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Keisuke Maeda

Project Assistant Professor

Nagoya University

JAPAN

View details

Chaoran Yang

Monash University Malaysia.

AUSTRALIA

View details

Christiane Zorbas

Université libre de Bruxelles

BELGIUM

View details

takeshi inagaki

Professor

JAPAN

View details

Marco Candeias

Junior Associate Professor - Principal Investigator

Kyoto University

JAPAN

View details

Juro Sakai

Professor

Tohoku University

JAPAN

View details

Shin-ichi Inoue

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yoshihiro Matsumura

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Epitranscriptomics in metabolic disease

Hypoxia activates <scp>SREBP2</scp> through Golgi disassembly in bone marrow‐derived monocytes for enhanced tumor growth

Epigenetic and environmental regulation of adipocyte function.

MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis.

Glutamine deficiency in solid tumor cells confers resistance to ribosomal RNA synthesis inhibitors.

Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis

Spatiotemporal dynamics of SETD5-containing NCoR–HDAC3 complex determines enhancer activation for adipogenesis

Ubiquitination‐dependent and ‐independent repression of target genes by SETDB1 reveal a context‐dependent role for its methyltransferase activity during adipogenesis

PPARα activation directly upregulates thrombomodulin in the diabetic retina.

Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content.

Collaborators (7)

Keisuke Maeda

Chaoran Yang

Christiane Zorbas

takeshi inagaki

Marco Candeias

Juro Sakai

Shin-ichi Inoue

Make your next move.